Abstract
l-Carnitine is a key molecule in the transfer of fatty acid across mitochondrial membranes. Bioavailable l-carnitine is either provided by an endogeneous biosynthesis or after intestinal absorption of dietary items containing l-carnitine. After intestinal absorption or hepatic biosynthesis, l-carnitine is transferred to organs whose metabolism is dependent upon fatty acid oxidation, such as skeletal muscle. To cross the muscle plasma membrane, there are several transporters involved. Among those transporters, OCTN2 is actually the only one to have been clearly characterized. Zidovudine is a commonly used inhibitor of human immunodeficiency virus (HIV) replication. Zidovudine has many side effects, including induction of myopathy characterized by a metabolic mitochondria dysfunction and a diminution of the muscle l-carnitine content. In this study, we described the characteristics of l-carnitine transport in C2C12 cells. We also demonstrated that zidovudine inhibited the l-carnitine transporter. This inhibition led to a significant reduction of the muscle cell growth. In C2C12 cells, the supplementation of l-carnitine prevented the effects of zidovudine and restored the normal cell growth.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
